2012 glutathione alzheimer's disease five authors Elevation of as a therapeutic strategy in Alzheimer Impaired Glutathione Synthesis in Neurodegeneration

Declaration of Competing Interest The authors report no conflict of interest.

On rare occasions, it can produce features similar to primary biliary cirrhosis due to progressive destruction of small bile ducts (vanishing duct syndrome)

As before, we represent the resting state of the enzyme as Enz-[Por-Fe(III)], and the active state oxo-ferryl Compound 1 as Enz-[Por+.-Fe(IV)=O]

Users stopping retinoids frequently report rapid regression of benefits within 4-8 weeks including increased breakouts sometimes exceeding pre-treatment levels (retinoid rebound), accelerated fine line reappearance approaching or surpassing baseline, skin texture deterioration returning to pre-treatment roughness, and psychological dependency from dramatic visible decline creating pressure for continuous use despite side effect burden